---
title: "The Real Barriers to Early-Stage Business Growth: A Conversation with Ike Cooke and Sophie Johnson"
description: Explore key insights from LYVA Labs on overcoming early-stage business growth barriers in health tech, turning interest into sustainable commercial success.
---

[Latest News](https://lyvalabs.com/news)

# [The Real Barriers to Early-Stage Business Growth: A Conversation with Ike Cooke and Sophie Johnson](https://lyvalabs.com/news/the-real-barriers-to-early-stage-business-growth-a-conversation-with-ike-cooke-and-sophie-johnson)

 Written by [LYVA Labs](https://lyvalabs.com/news/author/lyva-labs) | Mon, Nov 16, 2026

Promising businesses can lose momentum long before they scale, not because the product is weak, but because the route to adoption is unclear. Buyer complexity, budget pressure and competing priorities can all slow commercial traction, especially in health tech.

For founders, the challenge is turning early interest into a clearer, more confident path to market.

Through [Accelerate](https://lyvalabs.com/accelerate), LYVA Labs' 1:1 support programme, founders receive bespoke commercialisation advice and practical support to understand who has the authority, budget and motivation to buy. In health tech, where purchasing decisions are often complex and multi-layered, that understanding can be critical to commercial success.

Early interest is encouraging, but when does it become real commercial momentum?

We caught up with **LYVA Labs Commercial Advisors Ike Cooke** and **Sophie Johnson** to unpack the challenges founders face as they navigate early-stage growth and scale their businesses. Here is their advice for founders:

**Q: What is one of the biggest mistakes founders make when assessing early demand?**

**Ike:** Don’t mistake interest for commercial traction. Often, it's not even that the buyer doesn't want the product. Founders can build something substantially better than the incumbent and still struggle to gain traction when potential buyers face competing priorities, limited budgets or the risks involved in changing established processes. So, the real question isn't simply “do people want this?” - it's who experiences the problem, who champions the solution, and who has the authority and budget to buy it.

**Q: How early should founders start building buyer relationships?**

**Sophie:** As early as possible, identify alongside product development. Speaking to potential customers early on helps founders understand their needs, test assumptions and identify opportunities to trial or pilot their product. It's also important to understand who you're selling to, as the person using your product isn't always the person making the purchasing decision.

Building these relationships can take time, particularly if you're entering a new market or targeting one as complex as the NHS. Making use of existing networks, industry connections and support programmes like LYVA Labs Accelerate can help founders get in front of the right people, gain valuable feedback and shape their commercial strategy from the outset.

**Q: How can founders avoid spreading themselves too thin?**

**Ike:** Focus on the right opportunities. Many founders feel they must chase every customer, grant, investor and partnership opportunity. Trying to pursue everything at once slows progress. Focus creates momentum. It helps teams prioritise the most commercially relevant opportunities, use limited resources wisely and build a clearer story for the market.

That doesn't mean doing less for the sake of it. It means being intentional about which opportunities create the strongest evidence, the clearest route to revenue and the most credible path to growth. Where possible, founders should also build capable, trusted teams so the load doesn't sit with one person.

**Q: What is the “commercial chasm”, and why does it matter?**

Sophie: The commercial chasm is the gap between developing a promising innovation and proving it can become a commercially viable business. It's one of the biggest challenges early-stage companies face. Having a great product is only part of the journey; founders need to understand their target customers, whether B2B or B2C, develop a clear route to market and invest in consistent, targeted marketing. Ultimately, it's about turning innovation into a sustainable business with repeatable revenue and potential to scale.

Ike: It's relatively easy to generate excitement around a new product, secure industry interest or even win a few initial customers. Closing that commercial chasm means being completely dedicated to refining your product, its features and your pitch until interest converts into customers willing to buy. It's about moving from potential to proof – and having the discipline to focus relentlessly on that objective, rather than getting distracted by everything else. Ultimately, investors aren't just backing a good idea or exciting technology. They're backing a business capable of generating returns.

**Q: What questions should founders ask to bridge that gap?**

**Ike:** Bridging it means asking harder questions directly with your buyer, rather than relying only on an abstract persona-building exercise:

What evidence will make the buyer confident enough to sign?

What internal processes or competing priorities could quietly delay or block uptake?

What's the route to adoption?

Having a customer interested in your product doesn't mean they're ready or able to buy it. Founders need to understand what sits between initial interest and adoption, such as procurement, internal approvals, budget cycles, technical requirements, regulation, or proving economic value.

Mapping this early identifies the barriers before significant time and resource are invested, and shapes both the product and the commercial strategy around what buyers need to move forward.

**Where are you on your founder journey?** Discover how [**Accelerate**](https://lyvalabs.com/accelerate) can help take you to the next stage.

[Sign up to our mailing list to be the first to hear when applications open for 2027.](https://lyvalabs.com/subscribe-accelerate)

[View full post](https://lyvalabs.com/news/the-real-barriers-to-early-stage-business-growth-a-conversation-with-ike-cooke-and-sophie-johnson)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "LYVA Labs"
  },
  "dateModified" : "2026-11-16T16:01:55.563Z",
  "datePublished" : "2026-11-16T11:33:06Z",
  "headline" : "The Real Barriers to Early-Stage Business Growth: A Conversation with Ike Cooke and Sophie Johnson",
  "image" : {
    "@type" : "ImageObject",
    "height" : 2154,
    "url" : "https://26911784.fs1.hubspotusercontent-eu1.net/hubfs/26911784/1-1%20Ike%20and%20soph-38.jpeg",
    "width" : 5361
  },
  "mainEntityOfPage" : "https://lyvalabs.com/news/the-real-barriers-to-early-stage-business-growth-a-conversation-with-ike-cooke-and-sophie-johnson",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Latest News"
  }
}
```